Finland· FI-REL-REL12706
Foscan
A temoporfin product containing temoporfin, registered in Finland by Biolitec Pharma Ltd. Unit 9 A. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Temoporfin is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XD05 (temoporfin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Temoporfin · ATC L01XD05
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Temoporfin
- Manufacturer
- Biolitec Pharma Ltd. Unit 9 A
- Country
- Finland (FI)
- ATC code
- L01XD05
- ATC class
- Temoporfin
- Defined daily dose
- 10.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Temoporfin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumFoscan 1 mg/mlBiolitec Pharma
- SpainFOSCAN 1 mg/ml SOLUCION INYECTABLEBiolitec Pharma Limited
- United KingdomFoscan 1mg/1ml solution for injection vialsBiolitec Pharma Ltd
- CzechiaFOSCANbiolitec Pharma Ltd., Jena
- IcelandFoscanBiolitec Pharma Ltd.
- NetherlandsFoscan 1 mg/ml, oplossing voor injectieBiolitec Pharma
- PolandFoscanbiolitec Pharma Ltd.
- SwedenFoscan 1 mg/ml Injektionsvätska, lösningBiolitec Pharma Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b754d74-9364-4eae-a823-5af1bd99048b GET /v1/drugs/8b754d74-9364-4eae-a823-5af1bd99048b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "4 mg/ml",
"atc_label": "temoporfiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/01/197/001-002",
"fimea_rel_id": "REL12706",
"authorised_at": "2001-10-24"
}See everything about temoporfin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.